Cargando…

TGF-Beta as a Master Regulator of Diabetic Nephropathy

Diabetic nephropathy (DN) is one of the most common complications in diabetes mellitus and the leading cause of end-stage renal disease. TGF-β is a pleiotropic cytokine and has been recognized as a key mediator of DN. However, anti-TGF-β treatment for DN remains controversial due to the diverse role...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Li, Wang, Hong-Lian, Liu, Tong-Tong, Lan, Hui-Yao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345981/ https://www.ncbi.nlm.nih.gov/pubmed/34360646 http://dx.doi.org/10.3390/ijms22157881

Ejemplares similares

Role of TGF-Beta Signaling in Beta Cell Proliferation and Function in Diabetes
por: Wang, Hong-Lian, et al.
Publicado: (2022)

TGF-β as A Master Regulator of Aging-Associated Tissue Fibrosis
por: Ren, Li-Li, et al.
Publicado: (2023)

Heterogeneity in Pancreatic Cancer Fibroblasts—TGFβ as a Master Regulator?
por: Watt, Dale M., et al.
Publicado: (2021)

Sitagliptin ameliorates diabetic nephropathy by blocking TGF-β1/Smad signaling pathway
por: Wang, Dongdong, et al.
Publicado: (2018)

TGF-β – an excellent servant but a bad master
por: Kubiczkova, Lenka, et al.
Publicado: (2012)

Epigenetic Regulations in Diabetic Nephropathy
por: Lu, Zeyuan, et al.
Publicado: (2017)

Gremlin Regulates Podocyte Apoptosis via Transforming Growth Factor-β (TGF-β) Pathway in Diabetic Nephropathy
por: Wang, Xiao-Bing, et al.
Publicado: (2018)

The role of circular RNA in Diabetic Nephropathy
por: Tu, Chao, et al.
Publicado: (2022)

Mechanisms of Chinese Herbal Medicines for Diabetic Nephropathy Fibrosis Treatment
por: Jiang, Tong, et al.
Publicado: (2022)

Renoprotective Effect of Liraglutide Is Mediated via the Inhibition of TGF-Beta 1 in an LLC-PK1 Cell Model of Diabetic Nephropathy
por: Ninčević, Vjera, et al.
Publicado: (2022)

Regulation of the Homeostatic Unfolded Protein Response in Diabetic Nephropathy
por: Wang, Hongjie, et al.
Publicado: (2022)

Research Progress on the Pathological Mechanisms of Podocytes in Diabetic Nephropathy
por: Zhang, Lili, et al.
Publicado: (2020)

Chrysophanol Inhibits the Progression of Diabetic Nephropathy via Inactivation of TGF-β Pathway
por: Guo, Chuan, et al.
Publicado: (2020)

Regulation of the master regulator FOXM1 in cancer
por: Liao, Guo-Bin, et al.
Publicado: (2018)

TFPI2 suppresses the interaction of TGF-β2 pathway regulators to promote endothelial–mesenchymal transition in diabetic nephropathy
por: Guan, Guoying, et al.
Publicado: (2022)

Resveratrol ameliorates diabetic nephropathy in rats through negative regulation of the p38 MAPK/TGF-β1 pathway
por: Qiao, Yuan, et al.
Publicado: (2017)

A Study on the Mechanism of Milkvetch Root in the Treatment of Diabetic Nephropathy Based on Network Pharmacology
por: Piao, Chunli, et al.
Publicado: (2020)

TGF-BETA IN THE NATURAL HISTORY OF PROSTATE CANCER
por: Ahel, Jamal, et al.
Publicado: (2019)

Kirenol alleviates diabetic nephropathy via regulating TGF-β/Smads and the NF-κB signal pathway
por: Li, Jialin, et al.
Publicado: (2022)

Expression of transforming growth factor beta (TGF beta) receptors and expression of TGF beta 1, TGF beta 2 and TGF beta 3 in human small cell lung cancer cell lines.
por: Damstrup, L., et al.
Publicado: (1993)

Mitochondrial Dysfunction and Diabetic Nephropathy: Nontraditional Therapeutic Opportunities
por: Zhang, Ping Na, et al.
Publicado: (2021)

Nova1 is a master regulator of alternative splicing in pancreatic beta cells
por: Villate, Olatz, et al.
Publicado: (2014)

The Mechanism of Hyperglycemia-Induced Renal Cell Injury in Diabetic Nephropathy Disease: An Update
por: Wu, Tong, et al.
Publicado: (2023)

Diverse Roles of TGF-β/Smads in Renal Fibrosis and Inflammation
por: Lan, Hui Yao
Publicado: (2011)

Serum TGF-β1 as a Biomarker for Type 2 Diabetic Nephropathy: A Meta-Analysis of Randomized Controlled Trials
por: Mou, Xin, et al.
Publicado: (2016)

Diabetic nephropathy
por: Zelmanovitz, Themis, et al.
Publicado: (2009)

Pancreatic Adenocarcinoma Therapeutics Targeting RTK and TGF Beta Receptor
por: Yang, Hsin-Han, et al.
Publicado: (2021)

TGF-beta1 on osteoimmunology and the bone component cells
por: Kasagi, Shimpei, et al.
Publicado: (2013)

TGF-Beta Signaling in Bone with Chronic Kidney Disease
por: Iwasaki, Yoshiko, et al.
Publicado: (2018)

Hepcidin: regulation of the master iron regulator
por: Rishi, Gautam, et al.
Publicado: (2015)

Quercetin nanoparticle complex attenuated diabetic nephropathy via regulating the expression level of ICAM-1 on endothelium
por: Tong, Fei, et al.
Publicado: (2017)

TGF-β Signaling: From Tissue Fibrosis to Tumor Microenvironment
por: Chung, Jeff Yat-Fai, et al.
Publicado: (2021)

The Role of MicroRNAs in the Pathogenesis of Diabetic Nephropathy
por: Tang, Jian, et al.
Publicado: (2019)

Tip cells: Master regulators of tubulogenesis?
por: Weavers, Helen, et al.
Publicado: (2014)

Non-Coding RNAs: Master Regulators of Inflammasomes in Inflammatory Diseases
por: Wang, Wei, et al.
Publicado: (2021)

The Molecular Mechanism of Rhein in Diabetic Nephropathy
por: Zeng, Cong-Cong, et al.
Publicado: (2014)

A20: a master regulator of arthritis
por: Wu, Yongyao, et al.
Publicado: (2020)

Diabetic Nephropathy without Diabetes
por: López-Revuelta, Katia, et al.
Publicado: (2015)

Extracellular matrix regulates expression of the TGF-beta 1 gene
Publicado: (1993)

Asiatic Acid Inhibits Liver Fibrosis by Blocking TGF-beta/Smad Signaling In Vivo and In Vitro
por: Tang, Li-xia, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ql6htrc7rgtj5sqp7ifrl2lttr